Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
- 1 January 1996
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (8) , 867-870
- https://doi.org/10.1007/bf01084358
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Association between clozapine response and allelic variation in the 5-HT2C receptor geneNeuroReport, 1995
- Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal ControlsJournal of Cerebral Blood Flow & Metabolism, 1995
- The role of serotonin in depression and anxietyInternational Clinical Psychopharmacology, 1995
- Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disordersInternational Clinical Psychopharmacology, 1995
- Radiosynthesis of a new radioiodinated ligand for serotonin‐5HT2‐receptors, a promising tracer for γ‐emission tomographyJournal of Labelled Compounds and Radiopharmaceuticals, 1994
- Loss of brain 5-HT2receptors in Alzheimer's diseaseBrain, 1993
- Biological markers of depressionPsychological Medicine, 1991
- Ritanserin Reduces Abuse of Alcohol, Cocaine, and Fentanyl in RatsPharmacopsychiatry, 1991
- 5-Hydroxytryptamine and Its Role in MigraineEuropean Neurology, 1991
- Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicidesNeuropharmacology, 1984